Smith & Wesson Brands, Inc. Reports Third Quarter Fiscal 2021 Financial Results
Third Quarter Fiscal 2021 Consolidated Financial Highlights
- Quarterly net sales were
$257.6 million compared with$127.4 million for the comparable quarter last year, an increase of 102.2%. - Gross margin for the quarter was 42.6% compared with 28% for the comparable quarter last year.
- Quarterly GAAP net income was a record
$62.3 million , or$1.12 per diluted share, compared with$4.2 million , or$0.08 per diluted share, for the comparable quarter last year. - Quarterly non-GAAP net income was
$62.4 million , or$1.12 per diluted share, compared with$7.8 million , or$0.14 per diluted share, for the comparable quarter last year. GAAP to non-GAAP adjustments for income exclude costs related to the spin-off of the outdoor products and accessories business, COVID-19 related expenses, and other costs. For a detailed reconciliation, see the schedules that follow in this release. - Quarterly non-GAAP Adjusted EBITDAS was
$89.8 million , or 34.9% of net sales, compared with$15.0 million , or 11.8% of net sales, for the comparable quarter last year.
The amount and timing of any repurchases will depend on a number of factors, including price, trading volume, general market conditions, legal requirements, and other factors. The repurchases may be made on the open market, in block trades, or in privately negotiated transactions. Any shares of common stock repurchased under the program will be considered issued but not outstanding shares of the company's common stock.
Conference Call and Webcast
The company will host a conference call and webcast on
Reconciliation of
In this press release, certain non-GAAP financial measures, including "non-GAAP net income," "Adjusted EBITDAS," and "free cash flow" are presented. From time-to-time, the company considers and uses these supplemental measures of operating performance in order to provide the reader with an improved understanding of underlying performance trends. The company believes it is useful for itself and the reader to review, as applicable, both (1) GAAP measures that include (i) amortization of acquired intangible assets, (ii) transition costs, (iii) change in contingent consideration, (iv) CEO separation, (v) the tax effect of non-GAAP adjustments, (vi) COVID-19 expenses, (vii) net cash used in investing activities, (viii) interest expense, (ix) income tax expense, (x) depreciation and amortization, and (xi) stock-based compensation expenses; and (2) the non-GAAP measures that exclude such information. The company presents these non-GAAP measures because it considers them an important supplemental measure of its performance. The company's definition of these adjusted financial measures may differ from similarly named measures used by others. The company believes these measures facilitate operating performance comparisons from period to period by eliminating potential differences caused by the existence and timing of certain expense items that would not otherwise be apparent on a GAAP basis. These non-GAAP measures have limitations as an analytical tool and should not be considered in isolation or as a substitute for the company's GAAP measures. The principal limitations of these measures are that they do not reflect the company's actual expenses and may thus have the effect of inflating its financial measures on a GAAP basis.
About
|
|||
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||
(Unaudited) |
|||
As of: |
|||
|
|
||
(In thousands, except par value and share data) |
|||
ASSETS |
|||
Current assets: |
|||
Cash and cash equivalents |
$ 59,676 |
$ 125,011 |
|
Accounts receivable, net of allowances for credit losses of |
61,564 |
60,879 |
|
Inventories |
84,446 |
103,741 |
|
Prepaid expenses and other current assets |
8,574 |
7,556 |
|
Current assets of discontinued operations |
— |
94,673 |
|
Income tax receivable |
9,277 |
1,595 |
|
Total current assets |
223,537 |
393,455 |
|
Property, plant, and equipment, net |
145,398 |
147,739 |
|
Intangibles, net |
4,436 |
4,375 |
|
Goodwill |
19,024 |
19,024 |
|
Other assets of discontinued operations |
— |
148,485 |
|
Other assets |
13,456 |
16,437 |
|
405,851 |
729,515 |
||
LIABILITIES AND STOCKHOLDERS' EQUITY |
|||
Current liabilities: |
|||
Accounts payable |
$ 49,166 |
$ 31,476 |
|
Accrued expenses and deferred revenue |
37,805 |
57,678 |
|
Accrued payroll and incentives |
14,488 |
12,448 |
|
Accrued income taxes |
337 |
5,503 |
|
Accrued profit sharing |
10,860 |
2,197 |
|
Accrued warranty |
3,718 |
3,297 |
|
Current liabilties of discontinued operations |
— |
17,372 |
|
Total current liabilities |
116,374 |
129,971 |
|
Deferred income taxes |
773 |
457 |
|
Notes and loans payable, net of current portion |
— |
159,171 |
|
Finance lease payable, net of current portion |
39,060 |
39,873 |
|
Other non-current liabilities of discontinued operations |
— |
2,299 |
|
Other non-current liabilities |
11,935 |
10,626 |
|
Total liabilities |
168,142 |
342,397 |
|
Commitments and contingencies |
|||
Stockholders' equity: |
|||
Preferred stock, $.001 par value, 20,000,000 shares authorized, no shares issued or outstanding |
— |
— |
|
Common stock, $.001 par value, 100,000,000 shares authorized, 74,153,528 issued and 53,249,177 shares outstanding on |
74 |
74 |
|
Additional paid-in capital |
271,222 |
267,630 |
|
Retained earnings |
238,715 |
341,716 |
|
Accumulated other comprehensive income |
73 |
73 |
|
|
(272,375) |
(222,375) |
|
Total stockholders' equity |
237,709 |
387,118 |
|
$ 405,851 |
$ 729,515 |
|
||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME/(LOSS) |
||||||||
(Unaudited) |
||||||||
For the Three Months Ended |
For the Nine Months Ended |
|||||||
2021 |
2020 |
2021 |
2020 |
|||||
(In thousands, except per share data) |
||||||||
Net sales |
|
|
|
|
||||
Cost of sales |
147,955 |
91,729 |
433,073 |
232,989 |
||||
Gross profit |
109,679 |
35,687 |
303,174 |
103,586 |
||||
Operating expenses: |
||||||||
Research and development |
1,757 |
1,809 |
5,518 |
5,501 |
||||
Selling, marketing, and distribution |
10,487 |
10,465 |
32,095 |
30,839 |
||||
General and administrative |
17,054 |
14,603 |
62,061 |
47,915 |
||||
Total operating expenses |
29,298 |
26,877 |
99,674 |
84,255 |
||||
Operating income from continuing operations |
80,381 |
8,810 |
203,500 |
19,331 |
||||
Other income/(expense), net: |
||||||||
Other income/(expense), net |
952 |
(10) |
1,711 |
80 |
||||
Interest expense, net |
(550) |
(2,885) |
(3,356) |
(8,572) |
||||
Total other income/(expense), net |
402 |
(2,895) |
(1,645) |
(8,492) |
||||
Income from operations before income taxes |
80,783 |
5,915 |
201,855 |
10,839 |
||||
Income tax expense |
18,520 |
1,688 |
47,176 |
4,084 |
||||
Income from continuing operations |
$ 62,263 |
$ 4,227 |
|
$ 6,755 |
||||
Discontinued operations: |
||||||||
Income/(loss) from discontinued operations |
127 |
1,504 |
8,334 |
(1,839) |
||||
Net income |
$ 62,390 |
$ 5,731 |
|
$ 4,916 |
||||
Net income per share: |
||||||||
Basic - continuing operations |
$ 1.13 |
$ 0.08 |
$ 2.79 |
$ 0.12 |
||||
Basic - net income |
$ 1.13 |
$ 0.10 |
$ 2.94 |
$ 0.09 |
||||
Diluted - continuing operations |
$ 1.12 |
$ 0.08 |
$ 2.75 |
$ 0.12 |
||||
Diluted - net income |
$ 1.12 |
$ 0.10 |
$ 2.90 |
$ 0.09 |
||||
Weighted average number of common shares outstanding: |
||||||||
Basic |
55,137 |
55,064 |
55,515 |
54,919 |
||||
Diluted |
55,702 |
55,744 |
56,258 |
55,641 |
|
|||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||
(Unaudited) |
|||
For the Nine Months Ended |
|||
|
|
||
(In thousands) |
|||
Cash flows from operating activities: |
|||
Income from continuing operations |
$ 154,679 |
$ 6,755 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|||
Depreciation and amortization |
24,133 |
24,320 |
|
Loss on sale/disposition of assets |
148 |
310 |
|
Provision for losses on notes and accounts receivable |
(693) |
(98) |
|
Deferred income taxes |
316 |
(18) |
|
Change in fair value of contingent consideration |
— |
100 |
|
Stock-based compensation expense |
3,392 |
941 |
|
Changes in operating assets and liabilities: |
|||
Accounts receivable |
8 |
(8,503) |
|
Inventories |
19,295 |
(31,687) |
|
Prepaid expenses and other current assets |
(1,018) |
(3,797) |
|
Income taxes |
(12,831) |
(2,196) |
|
Accounts payable |
17,299 |
(2,398) |
|
Accrued payroll and incentives |
2,040 |
(6,754) |
|
Accrued profit sharing |
8,663 |
(1,006) |
|
Accrued expenses and deferred revenue |
(19,950) |
(1,584) |
|
Accrued warranty |
421 |
(526) |
|
Other assets |
1,226 |
1,281 |
|
Other non-current liabilities |
1,309 |
(1,777) |
|
Cash provided by/(used in) operating activities - continuing operations |
198,437 |
(26,637) |
|
Cash (used in)/provided by operating activities - discontinued operations |
(2,129) |
1,804 |
|
Net cash provided by/(used in) operating activities |
196,308 |
(24,833) |
|
Cash flows from investing activities: |
|||
Refunds on machinery and equipment |
310 |
— |
|
Payments to acquire patents and software |
(502) |
(303) |
|
Payments to acquire property and equipment |
(18,378) |
(10,504) |
|
Cash used by investing activities - continuing operations |
(18,570) |
(10,807) |
|
Cash used by investing activities - discontinued operations |
(1,143) |
(1,495) |
|
Net cash used in investing activities |
(19,713) |
(12,302) |
|
Cash flows from financing activities: |
|||
Proceeds from loans and notes payable |
25,000 |
228,225 |
|
Cash paid for debt issuance costs |
(450) |
(875) |
|
Payments on finance lease obligation |
(736) |
(663) |
|
Payments on notes and loans payable |
(185,000) |
(184,600) |
|
Distribution to AOUT |
(25,000) |
— |
|
Payments to acquire treasury stock |
(50,000) |
— |
|
Dividend distribution |
(5,594) |
— |
|
Proceeds from exercise of options to acquire common stock |
2,217 |
936 |
|
Payment of employee withholding tax related to restricted stock units |
(2,201) |
(594) |
|
Cash (used in)/provided by financial activities - continuing operations |
(241,764) |
42,429 |
|
Cash used in financial activities - discontinued operations |
(166) |
— |
|
Net cash (used in)/provided by financing activities |
(241,930) |
42,429 |
|
Net (decrease)/increase in cash and cash equivalents |
(65,335) |
5,294 |
|
Cash and cash equivalents, beginning of period |
125,011 |
40,853 |
|
Cash and cash equivalents, end of period |
$ 59,676 |
$ 46,147 |
|
Supplemental disclosure of cash flow information |
|||
Cash paid for: |
|||
Interest |
$ 2,745 |
$ 8,422 |
|
Income taxes |
$ 63,525 |
$ 5,755 |
|
|||||||||||||||
For the Three Months Ended |
For the Nine Months Ended |
||||||||||||||
|
|
|
|
||||||||||||
$ |
% of Sales |
$ |
% of Sales |
$ |
% of Sales |
$ |
% of Sales |
||||||||
GAAP gross profit |
|
42.6% |
|
28.0% |
|
41.2% |
|
30.8% |
|||||||
COVID-19 |
22 |
0.0% |
— |
— |
517 |
0.1% |
— |
— |
|||||||
Non-GAAP gross profit |
|
42.6% |
|
28.0% |
|
41.2% |
|
30.8% |
|||||||
GAAP operating expenses |
$ 29,298 |
11.4% |
|
21.1% |
$ 99,674 |
13.5% |
$ 84,255 |
25.0% |
|||||||
Amortization of acquired intangible assets |
(83) |
0.0% |
(36) |
0.0% |
(248) |
0.0% |
(258) |
-0.1% |
|||||||
Transition costs |
(20) |
0.0% |
(1,025) |
-0.8% |
(7,953) |
-1.1% |
(1,189) |
-0.4% |
|||||||
COVID-19 |
(58) |
0.0% |
— |
— |
(617) |
-0.1% |
— |
— |
|||||||
Spin related stock-based compensation |
— |
— |
— |
— |
(442) |
-0.1% |
— |
— |
|||||||
CEO separation |
— |
— |
(3,844) |
-3.0% |
— |
— |
(3,844) |
-1.1% |
|||||||
Non-GAAP operating expenses |
$ 29,137 |
11.3% |
|
17.2% |
$ 90,414 |
12.3% |
$ 78,964 |
23.5% |
|||||||
GAAP operating income |
$ 80,381 |
31.2% |
$ 8,810 |
6.9% |
|
27.6% |
$ 19,331 |
5.7% |
|||||||
Amortization of acquired intangible assets |
83 |
0.0% |
36 |
0.0% |
248 |
0.0% |
258 |
0.1% |
|||||||
Transition costs |
20 |
0.0% |
1,025 |
0.8% |
7,953 |
1.1% |
1,189 |
0.4% |
|||||||
COVID-19 |
80 |
0.0% |
— |
— |
1,134 |
0.2% |
— |
— |
|||||||
Spin related stock-based compensation |
— |
— |
— |
— |
442 |
0.1% |
— |
— |
|||||||
CEO separation |
— |
— |
3,844 |
3.0% |
— |
— |
3,844 |
1.1% |
|||||||
Non-GAAP operating income |
$ 80,564 |
31.3% |
|
10.8% |
|
29.0% |
$ 24,622 |
7.3% |
|||||||
GAAP income from continuing operations |
$ 62,263 |
24.2% |
$ 4,227 |
3.3% |
|
21.0% |
$ 6,755 |
2.0% |
|||||||
Amortization of acquired intangible assets |
83 |
0.0% |
36 |
0.0% |
248 |
0.0% |
258 |
0.1% |
|||||||
Transition costs |
20 |
0.0% |
1,025 |
0.8% |
7,953 |
1.1% |
1,189 |
0.4% |
|||||||
COVID-19 |
80 |
0.0% |
— |
— |
1,134 |
0.2% |
— |
— |
|||||||
Change in contingent consideration |
— |
— |
— |
— |
— |
— |
(100) |
0.0% |
|||||||
Spin related stock-based compensation |
— |
— |
— |
— |
442 |
0.0% |
— |
— |
|||||||
CEO separation |
— |
— |
3,844 |
3.0% |
— |
— |
3,844 |
1.1% |
|||||||
Tax effect of non-GAAP adjustments |
(46) |
0.0% |
(1,324) |
-1.0% |
(2,444) |
-0.3% |
(1,402) |
-0.4% |
|||||||
Non-GAAP income from continuing operations |
$ 62,400 |
24.2% |
$ 7,808 |
6.1% |
|
22.0% |
$ 10,544 |
3.1% |
|||||||
GAAP income from continuing operations per share - diluted |
$ 1.12 |
$ 0.08 |
$ 2.75 |
$ 0.12 |
|||||||||||
Amortization of acquired intangible assets |
— |
— |
— |
— |
|||||||||||
Transition costs |
— |
0.02 |
0.14 |
0.02 |
|||||||||||
COVID-19 |
— |
— |
0.02 |
— |
|||||||||||
Change in contingent consideration |
— |
— |
— |
— |
|||||||||||
Spin related stock-based compensation |
— |
— |
0.01 |
— |
|||||||||||
CEO separation |
— |
0.07 |
— |
0.07 |
|||||||||||
Tax effect of non-GAAP adjustments |
— |
(0.02) |
(0.04) |
(0.03) |
|||||||||||
Non-GAAP income from continuing operations per share - diluted |
$ 1.12 |
$ 0.14 |
(a) |
$ 2.88 |
$ 0.19 |
(a) |
(a) Non-GAAP net income per share does not foot due to rounding. |
|
|||||||
RECONCILIATION OF OPERATING CASH FLOW FROM CONTINUING OPERATIONS TO FREE CASH FLOW |
|||||||
For the Three Months Ended |
For the Nine Months Ended |
||||||
|
|
|
|
||||
Net cash (provided by)/used in operating activities |
$ 60,349 |
$ 2,047 |
$ 198,437 |
$ (26,637) |
|||
Net cash used in investing activities |
(3,256) |
(2,279) |
(18,570) |
(10,807) |
|||
Free cash flow |
$ 57,093 |
$ (232) |
$ 179,867 |
$ (37,444) |
|
||||||||
RECONCILIATION OF GAAP INCOME FROM CONTINUING OPERATIONS TO NON-GAAP ADJUSTED EBITDAS |
||||||||
For the Three Months Ended |
For the Nine Months Ended |
|||||||
|
|
|
|
|||||
GAAP income from continuing operations |
$ 62,263 |
$ 4,227 |
$ 154,679 |
$ 6,755 |
||||
Interest expense |
592 |
2,869 |
3,471 |
8,919 |
||||
Income tax expense |
18,520 |
1,688 |
47,176 |
4,084 |
||||
Depreciation and amortization |
7,017 |
7,509 |
23,264 |
23,776 |
||||
Stock-based compensation expense |
1,317 |
1,554 |
3,392 |
4,375 |
||||
Change in contingent consideration |
— |
— |
— |
(100) |
||||
COVID-19 |
80 |
— |
1,134 |
— |
||||
Transition costs |
20 |
1,025 |
7,953 |
1,189 |
||||
CEO separation |
— |
(3,844) |
— |
(3,844) |
||||
Non-GAAP Adjusted EBITDAS |
$ 89,809 |
$ 15,028 |
$ 241,069 |
$ 45,154 |
Contact:
investorrelations@smith-wesson.com
(413) 747-3448
View original content to download multimedia:http://www.prnewswire.com/news-releases/smith--wesson-brands-inc-reports-third-quarter-fiscal-2021-financial-results-301241002.html
SOURCE